**Core Concept**
The clinical presentation of arthritis, malar rash, oral ulcers, and serositis in a young female is highly suggestive of Systemic Lupus Erythematosus (SLE), a chronic autoimmune disease characterized by the presence of autoantibodies against various nuclear and cytoplasmic antigens. The presence of these symptoms is a classic example of the "Butterfly Rash" and "Malar Rash" associated with SLE.

**Why the Correct Answer is Right**
Anti-nuclear antibodies (ANA) are a group of autoantibodies that are directed against the cell nucleus and are a hallmark of SLE. These antibodies are formed when the immune system mistakenly attacks the body's own tissues, leading to inflammation and tissue damage. The presence of ANA is a sensitive but not specific marker for SLE, as it can also be present in other autoimmune diseases. In SLE, the ANA is typically directed against the double-stranded DNA, histones, and other nuclear antigens.

**Why Each Wrong Option is Incorrect**
**Option B:** Anti-collagen antibody is more commonly associated with Goodpasture's syndrome, a rare autoimmune disease characterized by the presence of antibodies against the basement membrane of the lungs and kidneys.

**Option C:** Anti-epithelial antibodies are more commonly associated with pemphigus, a group of autoimmune diseases characterized by the presence of antibodies against the skin and mucous membranes.

**Option D:** Antigen-antibody complexes are indeed formed in SLE, but the presence of these complexes is not directly detectable through a single investigation. Instead, they can be inferred through the presence of other laboratory abnormalities such as low complement levels.

**Clinical Pearl / High-Yield Fact**
The presence of ANA in a patient with a compatible clinical presentation is a critical diagnostic clue for SLE. However, it's essential to note that a negative ANA does not rule out SLE, as some patients may have a low-titer or specific ANA that is not detectable by standard tests.

**✓ Correct Answer: A. Anti nuclear antibody**